RxDoctor Payments Data

Kirti Jain, MD

Family Medicine · Allen Park, MINPI 1316926165

Payments from drug & device makers

$2,115in general payments, 2019–2025

Across 160 payments — averaging $13.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$783
  • Astellas Pharma US Inc$412
  • AstraZeneca$293
  • Pfizer$118
  • Cardiovascular Systems Inc.$116
  • Genentech USA, Inc.$59
  • plus $334 from 14 others

What the payments were for

  • Food & beverage$2,00395%
  • Education$1125%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,115 in reported general payments places this provider in the 80th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$108,561
Medicare patients
116
Services billed
1,098

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter167$157,888
JardianceEmpagliflozin89$107,685
OzempicSemaglutide70$67,772
EliquisApixaban55$49,809
JanuviaSitagliptin Phosphate41$47,002
TrulicityDulaglutide45$43,941
FarxigaDapagliflozin Propanediol23$24,800
XareltoRivaroxaban11$15,381
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr19$12,575
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen781$9,664
Varenicline Tartrate16$8,555
Atorvastatin Calcium693$7,472
Albuterol Sulfate HfaAlbuterol Sulfate174$7,114
Metoprolol Succinate395$6,870
BrilintaTicagrelor11$6,695

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta$783$170,462186 claims
Boehringer IngelheimJardiance$39$107,68589 claims
Novo NordiskOzempic$11$67,77270 claims
PfizerEliquis$118$49,80955 claims
MerckJanuvia$12$47,00241 claims
Lilly USA, LLCTrulicity$27$43,94145 claims
AstraZenecaFarxiga, Brilinta, Symbicort$293$35,33746 claims
Johnson & JohnsonXarelto$17$15,38111 claims
AbbVieSynthroid$32$1,30715 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Allen Park

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →